Literature DB >> 26527005

SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase.

Hengrui Zhu1, Shancheng Ren2, Benjamin G Bitler1, Katherine M Aird1, Zhigang Tu1, Emmanuel Skordalakes1, Yasheng Zhu2, Jun Yan3, Yinghao Sun4, Rugang Zhang5.   

Abstract

The SPOP gene, which encodes an E3 ubiquitin ligase adaptor, is frequently mutated in a number of cancer types. However, the mechanisms by which SPOP functions as a tumor suppressor remain poorly understood. Here, we show that SPOP promotes senescence, an important tumor suppression mechanism, by targeting the SENP7 deSUMOylase for degradation. SPOP is upregulated during senescence. This correlates with ubiquitin-mediated degradation of SENP7, which promotes senescence by increasing HP1α sumoylation and the associated epigenetic gene silencing. Ectopic wild-type SPOP, but not its cancer-associated mutants, drives senescence. Conversely, SPOP knockdown overcomes senescence. These phenotypes correlate with ubiquitination and degradation of SENP7 and HP1α sumoylation, subcellular re-localization, and its associated gene silencing. Furthermore, SENP7 is expressed at higher levels in prostate tumor specimens with SPOP mutation (n = 13) compared to those with wild-type SPOP (n = 80). In summary, SPOP acts as a tumor suppressor by promoting senescence through degrading SENP7.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527005      PMCID: PMC4644472          DOI: 10.1016/j.celrep.2015.09.083

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  37 in total

Review 1.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

2.  Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways.

Authors:  Tianwei Li; Rasa Santockyte; Rong-Fong Shen; Ephrem Tekle; Guanghui Wang; David C H Yang; P Boon Chock
Journal:  J Biol Chem       Date:  2006-09-29       Impact factor: 5.157

3.  Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Authors:  Jean-Philippe P Theurillat; Namrata D Udeshi; Wesley J Errington; Tanya Svinkina; Sylvan C Baca; Marius Pop; Peter J Wild; Mirjam Blattner; Anna C Groner; Mark A Rubin; Holger Moch; Gilbert G Prive; Steven A Carr; Levi A Garraway
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

4.  SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.

Authors:  Guoqiang Li; Weimin Ci; Subhradip Karmakar; Ke Chen; Ruby Dhar; Zhixiang Fan; Zhongqiang Guo; Jing Zhang; Yuwen Ke; Lu Wang; Min Zhuang; Shengdi Hu; Xuesong Li; Liqun Zhou; Xianghong Li; Matthew F Calabrese; Edmond R Watson; Sandip M Prasad; Carrie Rinker-Schaeffer; Scott E Eggener; Thomas Stricker; Yong Tian; Brenda A Schulman; Jiang Liu; Kevin P White
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

Review 5.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

6.  BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3.

Authors:  Lai Xu; Yue Wei; Jerome Reboul; Philippe Vaglio; Tae-Ho Shin; Marc Vidal; Stephen J Elledge; J Wade Harper
Journal:  Nature       Date:  2003-09-03       Impact factor: 49.962

7.  The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase.

Authors:  Lionel Pintard; John H Willis; Andrew Willems; Jacque-Lynne F Johnson; Martin Srayko; Thimo Kurz; Sarah Glaser; Paul E Mains; Mike Tyers; Bruce Bowerman; Matthias Peter
Journal:  Nature       Date:  2003-09-03       Impact factor: 49.962

8.  Organoid cultures derived from patients with advanced prostate cancer.

Authors:  Dong Gao; Ian Vela; Andrea Sboner; Phillip J Iaquinta; Wouter R Karthaus; Anuradha Gopalan; Catherine Dowling; Jackline N Wanjala; Eva A Undvall; Vivek K Arora; John Wongvipat; Myriam Kossai; Sinan Ramazanoglu; Luendreo P Barboza; Wei Di; Zhen Cao; Qi Fan Zhang; Inna Sirota; Leili Ran; Theresa Y MacDonald; Himisha Beltran; Juan-Miguel Mosquera; Karim A Touijer; Peter T Scardino; Vincent P Laudone; Kristen R Curtis; Dana E Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Stephen B Solomon; James A Eastham; Ping Chi; Brett Carver; Mark A Rubin; Howard I Scher; Hans Clevers; Charles L Sawyers; Yu Chen
Journal:  Cell       Date:  2014-09-04       Impact factor: 41.582

9.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.

Authors:  Oliver Bischof; Klaus Schwamborn; Nadine Martin; Andreas Werner; Claudio Sustmann; Rudolf Grosschedl; Anne Dejean
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

View more
  27 in total

1.  Detection of the Ubiquitinome in Cells Undergoing Oncogene-Induced Senescence.

Authors:  Hengrui Zhu; Linh Le; Hsin-Yao Tang; David W Speicher; Rugang Zhang
Journal:  Methods Mol Biol       Date:  2017

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

Review 3.  Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Zhiwei Wang; Brian J North; Kaixiong Tao; Xiangpeng Dai; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-08       Impact factor: 10.680

Review 4.  The Immortal Senescence.

Authors:  Anna Bianchi-Smiraglia; Brittany C Lipchick; Mikhail A Nikiforov
Journal:  Methods Mol Biol       Date:  2017

Review 5.  From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence.

Authors:  Christopher D Wiley; Judith Campisi
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

6.  Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.

Authors:  Fei Wu; Xiangpeng Dai; Wenjian Gan; Lixin Wan; Min Li; Nicholas Mitsiades; Wenyi Wei; Qiang Ding; Jinfang Zhang
Journal:  Cancer Lett       Date:  2016-10-22       Impact factor: 8.679

7.  Uterine function in the mouse requires speckle-type poz protein.

Authors:  Lan Hai; Maria M Szwarc; Bin He; David M Lonard; Ramakrishna Kommagani; Francesco J DeMayo; John P Lydon
Journal:  Biol Reprod       Date:  2018-06-01       Impact factor: 4.285

Review 8.  SPOP and cancer: a systematic review.

Authors:  Alison Clark; Marieke Burleson
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

9.  SPOP-mediated degradation of BRD4 dictates cellular sensitivity to BET inhibitors.

Authors:  Xiangpeng Dai; Zhiwei Wang; Wenyi Wei
Journal:  Cell Cycle       Date:  2017       Impact factor: 4.534

Review 10.  The diverse roles of SPOP in prostate cancer and kidney cancer.

Authors:  Zhiwei Wang; Yizuo Song; Miaomiao Ye; Xiaoming Dai; Xueqiong Zhu; Wenyi Wei
Journal:  Nat Rev Urol       Date:  2020-04-30       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.